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Type-1 plasminogen activator inhibitor (PAI-1), the primary physiological inhibitor of endogenous plasminogen activators, modulates fibrinolysis, cell migration, and tissue repair. To determine whether genetic expression of PAI-1 is augmented in the walls of vessels exposed to thrombi but not to a direct physical insult such as electrical injury, we induced arterial thrombosis in rabbit carotid arteries with intraluminal surgical silk sutures and performed in situ hybridization for PAI-1 messenger RNA (mRNA) and immunohistochemistry for PAI-1 antigen at selected intervals. PAI-1 activity in plasma remained virtually constant In contrast, PAI-1 mRNA increased in endothelial cells juxtaposed to thrombi, in smooth muscle cells adjacent to the neointima, and in macrophages surrounding the suture material. PAI-1 protein was detected in regions in which PAI-1 mRNA was expressed. The increased expression of PAI-1 mRNA colocalized with PAI-1 protein in the endothelium juxtaposed to thrombi may potentiate thrombosis by shifting the local balance between fibrinolysis and thrombosis toward thrombosis. Furthermore, it may alter vascular remodeling and predispose to stenosis after interventions such as angioplasty, in which local thrombosis cannot be avoided. lasminogen activator inhibitor type-1 (PAI-1) is the primary physiological inhibitor of tissuetype (t-PA) and urokinase-type plasminogen activators. Activation of plasminogen not only underlies fibrinolysis but also influences cell migration, epithelial cell differentiation, and tissue repair. Thus, increased expression of PAI-1 may locally attenuate fibrinolysis, thereby perpetuating thrombosis and simultaneously predisposing to vasculopathy. 1 We have previously shown that products of activated platelets induce production of PAI-1 in cultured vascular endothelial cells 2 and in vivo 3 and that thrombosis and thrombolysis increase plasma PAI-1 levels in vivo in rabbits. 4 Synthesis of PAI-1 in smooth muscle cells in vitro is influenced by transforming growth factor-^ (TGF-/3) and plateletderived growth factor (PDGF). 5 Because vascular injury and atherogenesis are manifested by proliferation and migration of arterial smooth muscle cells 6 " 8 into the neointima and because PDGF and TGF-/3 are released from platelets as they degranulate while they participate in thrombosis, we hypothesized that locally increased synthesis of PAI-1 secondary to thrombosis may intensify vascular injury by altering the deposition of extracellular matrix.
Both the deposition of fibrin and the organization of thrombi appear to contribute to the development of atherosclerotic plaques. 9 In human atheroma, PAI-1 mRNA is seen in intimal cells resembling mesenchyme that is associated with organizing thrombi and in adjacent medial smooth muscle cells. 10 In studies of longterm arterial thrombosis in rats 11 and rabbits, 12 vessel walls in contact with arterial thrombi exhibit fibrous intimal thickening.
The present study was performed to determine whether mesenchymal-like cells seen in organizing arterial thrombi expressed transcripts of PAI-1 and to determine whether vessel walls exposed to thrombi, but not subjected to a direct physical insult such as electrically induced endothelial injury, exhibit augmented gene expression of PAI-1. PAI-1 gene expression was assessed by in situ hybridization, and the presence of PAI-1 protein was evaluated by immunohistochemistry in the walls of rabbit carotid arteries exposed to induced intraluminal thrombi.
Methods

Materials
Goat anti-rabbit thrombomodulin antibody was kindly provided by Dr. Naomi L. Esmon (Oklahoma Medical Research Foundation). 13 Antimacrophage antibody RAM-11 was kindly provided by Dr. Allen M. Gown (University of Washington).
14 PAI-1 cDNA was kindly provided by Dr. T.C. Wun (Monsanto). 15 Purified human PAI-1 protein and goat anti-human PAI-1 antibody were acquired from American Diagnostics; antia-actin antibody HHF-35 was purchased from Enzo Biochemical; and anti-factor VHI-related antigen an-tibody was obtained from Atlantic Antibodies. Hydrogen peroxide, hematoxylin, trypsin, poly-L-lysine, dithiothreitol, acetic anhydride, triethanolamine, RNase, and diethyl pyrocarbonate were obtained from Sigma Chemical Co. Paraformaldehyde, methanol, calcium chloride, formamide, Wheaten staining jars, coverslips, and micro slide glasses were acquired from Fisher. Proteinase K and transfer RNA were obtained from Boehringer Mannheim; EcoRl and Sal I from USB; PBluescript SK + vector and RNA transcription kits from Stratagene; RNaid from Bio 101; Elite ABC kit and 3,3'-diaminobenzidine substrate kits from Vector; uridine S'-fo-^PJtriphosphate, triethylammonium salt, and cell proliferation kit from Amersham; DPX from BDH Laboratory Supplies; and emulsion NTB-2, fixer, and developer D-19 from Kodak.
Cell Culture and Purification of Rabbit PAI-1 Protein
Human umbilical vein endothelial cells were isolated by the method of Jaffe et al 16 and cultured as previously described. 2 Rabbit aortic endothelial cells, kindly provided by Dr. Alan M. Fogelman (University of California at Los Angeles), and adult rabbit myocytes, kindly provided by Dr. Peter B. Corr (Washington University), were cultured as previously described.
1718 Rabbit endothelial PAI-1 was purified from conditioned media of rabbit aortic endothelial cells by the method of van Mourik et al. 19 
Experimental Procedures
All protocols conformed to the Position of the American Heart Association on Research Animal Use (November 11, 1984) and were approved by the Animal Studies Committee of Washington University. New Zealand White rabbits were studied after anesthesia with 20 mg/kg body wt ketamine i.m. and 8 mg/kg body wt xylazine i.m.
Persistent arterial thrombi were conventionally induced in the carotid arteries of the rabbits. 11 Briefly, endotoxin-free sterile surgical silk sutures (4-0, DavisGeek, Danbury, Conn.) were passed into and out of the vessel lumen of one carotid artery in each animal with the use of curved needles. The silk was tied loosely on the adventitial side. Each suture was inserted such that entry was 7 mm upstream of the exit wound. The incision was closed in two layers. Contralateral arteries served as controls. Sham operation was performed in two animals, with sutures passed through the vessel wall and then removed. At selected intervals after operation, blood samples were collected for measurement of PAI-1 activity. Both experimental and control contralateral carotid arteries were harvested. Plasma samples were separated by centrifugation at 4°C at 2,000g for 15 minutes, and aliquots were frozen immediately in liquid nitrogen for storage at -70°C until assay.
Determination of PAI-1 Activity
Plasma PAI-1 activity was assayed spectrophotometricalry with a modification of a procedure developed by Chmielewska and Wiman 20 as described previously. One arbitrary unit (AU) of plasma PAI-1 was defined as the amount of activity that inhibited one international unit of t-PA over 10 minutes. Serial dilutions of rabbit plasma were used for construction of standard curves. Results were expressed as arbitrary units per milliliter.
Immunohistochemistry
Endothelial cells and myocytes cultured on circular glass coverslips for 16 hours were rinsed in phosphatebuffered saline (PBS), fixed in acetone (10 minutes, -20°C), and dried overnight at 42°C. Serial frozen sections adjacent to sections used for in situ hybridization were used for immunohistochemical detection of PAI-1 antigen and identification of specific cell types. HHF-35 antibodies were used for identification of smooth muscle cells, RAM-11 for macrophages, and anti-rabbit thrombomodulin and anti-factor VIH-related antigen for endothelial cells.
Immunohistochemical procedures were performed as previously described. 21 Briefly, the cells or sections were incubated in methanol containing 0.25% H 2 O 2 for 15 minutes. After washing with PBS, they were incubated with normal serum for 30 minutes (horse serum for assay of HHF-35 and RAM-11 and goat serum for assay of PAI-1 antigen, factor Vlll-related antigen, and thrombomodulin), primary antibody (60 minutes), biotinylated second antibody (60 minutes at 37°C), and avidin-biotin peroxidase complexes (30 minutes). Peroxidase was visualized with 3,3'-diaminobenzidine and counterstained with hematoxylin.
For immunostaining for PAI-1 antigen, factor VIIIrelated antigen and thrombomodulin sections were pretreated with trypsin (0.1% trypsin in 0.1% CaCl 2 and 0.05 M tris(hydroxymethyl)aminomethane hydrochloride [Tris-HCl], pH 7.6) for 10 minutes. The cross-reactivity of the antibody against human PAI-1 with rabbit PAI-1 was verified by reactivity in a single band at 46 kd on Western blots of purified human PAI-1 antigen, purified rabbit PAI-1 antigen, and immunoprecipitated PAI-1 protein (results not shown). Rabbit aortic endothelial cells, as well as human umbilical endothelial cells on coverslips incubated with anti-PAI-1 antibody, exhibited distinct cytoplasmic staining ( Figure 1 ). Endothelial cells incubated with normal goat serum or myocytes incubated with anti-PAI-1 antibody used as negative controls exhibited no positive reactions.
To characterize the rate of DNA synthesis, rabbits were injected with 30 mg/kg body wt 5-bromo-2'-deoxyuridine (BrdU) and 5-fluoro-2'-deoxvuridine (10:1 ratio) i.p. Two hours after injection, tissues were harvested. Immunohistochemical studies were performed conventionally with nuclease digestion of DNA to facilitate anti-BrdU antibody access.
In Situ Hybridization
In situ hybridization was performed as described by Simmons et al. 22 For preparations of tissue sections, rabbits were anesthetized with ketamine and xylazine. Perfusion fixation was performed in vivo via the left ventricle, and blood was withdrawn from the right atrium. Perfusion media included physiological saline followed by ice-cold 4% paraformaldehyde in 0.02 M sodium phosphate buffer, pH 7.3. Tissue was harvested, dissected, incubated in the same fixative for 4 hours at 4°C, washed with PBS twice, and stored at -70°C. Sections (10 fim) were cut in a cryostat and placed on 0.01% poly-L-lysine-coated slides. The slides were then postfixed, dehydrated in graded alcohol, dried in a vacuum desiccator for 1 hour, and stored at -70°C until pretreatment and hybridization. The slides were treated Figure 3 , the large open arrow to the region shown in Figure 4 , the large black closed arrow to the region shown in Figure 5 , and the black arrowhead to the region shown in Figure 6 (x27.5). mid containing a 0.9-kb human PAI-1 cDNA insert was linearized by restriction digestion with EcoRl or 5a/ I (for antisense and sense, respectively) and transcribed with T7 or T3 RNA porymerase in the presence of S-labeled uridine triphosphate. After transcription, DNase was added to digest the remaining template. Transcripts were isolated from the unincorporated nucleotides by treatment with RNaid. After quantification of radioactivity by liquid scintillation spectrometry, an RNA probe comprising 2.5 x 10 7 cpm was mixed with 2.5 mg transfer RNA and 0.05 M dithiothreitol. The final volume was adjusted to 1.0 ml with a 0.1% solution of diethyl pyrocarbonate (to denature nucleases) and heated for 5 minutes at 65°C. This solution was added to 4 ml of hybridization buffer (50% deionized formamide, 10% dextran sulfate, l x Denhardt's solution, 0.3 M NaCl, 10 mM Tris-HCl, and 1 mM EDTA, pH 8.0) and maintained at -20°C. After addition of 75 fi\ of the hybridization solution, slides were covered with coverslips, sealed with DPX to prevent drying, and incubated at 60°C for 20 hours.
After hybridization, the slides were washed with 4x SSC for 1 hour; treated with RNase (2% RNase A in 0.5 M NaCl, 10 mM Tris-HCl, and 1 mM EDTA, pH 8.0) for 30 minutes at 37°C; washed with 2x SSC, l x SSC, and 0.5 x SSC for 10 minutes each; and incubated in 0.1 x SSC for 30 minutes at 75°C. The slides were then dehydrated, dried in a vacuum desiccator, dipped in emulsion (Kodak NTB-2 diluted 1:1 with water), placed in light-proof containers, stored at 4°C for 2-4 weeks, 
antibody. Dark brown (positive) immunostaining is evident in the cytoplasm of multinucleated giant cells (open arrows). Panel C: Section corresponding to that in panel A but stained with RAM-11, an anti-macrophage antibody. Cells positive for PAI-1 expression are seen to be macrophages also positive for staining with RAM-11 (open arrows indicate representative reactive cells). PAI-1, type-1 plasminogen activator inhibitor. Magnification for all panels, X412.5.
and developed with Kodak developer D-19 and fixer, after which counterstaining was performed with hematoxylin and eosin.
Analysis of Slides
Slides were viewed on a Nikon microscope (Nikon, Tokyo, Japan). Four separate sections from each artery were subjected to in situ hybridization and immunohistochemistry study and analyzed by two independent observers.
Results
Hisiological Analysis of the Carotid Arteries
The appearance of the carotid arterial thrombi was consistent with that in previous reports. 11 The morphology of cells in the carotid arteries examined was indicative of the following and was seen in all of the arteries examined. One week after the experimental procedure had been performed to induce thrombosis, the intraluminal portion of the suture was covered by thrombus comprising fibrin, polymorphonuclear leukocytes, and platelets. A few erythrocytes were present. The endothelium adjacent to the thrombus was proliferating and appeared to be growing over the thrombus from the margin where it met the intima. Two weeks after the procedure, endothelialization of the surface of the thrombi appeared to be virtually complete. The cells within the organizing thrombus were elongated and were shown later to be smooth muscle cells apparently originating from the luminal surface.
After 4 weeks, the thrombus was fully organized into a pseudointima populated with smooth muscle cells. It was completely covered by endothelium (Figure 2) . Accumulation of multinucleated giant cells and neovascularization were evident around the suture (Figure 3 ). Marked intimal thickening was apparent surrounding the original, intraluminal portion of the suture. The intimal thickening reflected the presence of many smooth muscle cells, some macrophages (Figure 4) , and endothelial cells on the surface ( Figure 5 ). Intimal thickening of diverse extent was also evident at sites away from the injury (Figure 6 ). At this stage, leukocytes and platelets, recognizable in the area 1 week after the induction of thrombus, were no longer evident. In the tunica media around the induced lesion, edema and neovascularization were present.
Histological changes in carotid arteries at 6, 8, and 10 weeks after induction of thrombosis were generally similar to those seen after 4 weeks. Contralateral noninjured carotid arteries, serving as controls, exhibited no histological changes ( Figure 6 ). Carotid arteries from animals subjected to sham operation did not exhibit any histological changes.
Activity of Plasma PAI-1
The baseline activity of plasma PAI-1 was 3.1 ±1.6 (mean±SD) AU/ml (Table 1) . To determine whether the surgical procedure itself altered PAI-1 activity in a sustained fashion (PAI-1 is an acute-phase reactant), plasma samples were obtained 1 day and 1, 2, 4, 8, and 10 weeks after surgery. PAI-1 activity in plasma at each of these intervals is shown in Table 1 . It was increased slightly at 1 week but subsequently returned to values at baseline.
In Situ Hybridization and Immunohistochemistry
At selected intervals (1, 2, 4, 6, 8, and 10 weeks after induction of thrombosis), the walls of the carotid arter- ies were characterized by in situ hybridization. Vessels from 12 rabbits were evaluated. Cells positive for PAI-1 mRNA hybridization were seen in all of them. Although control vessels exhibited virtually no signals, strong positive hybridization signals for PAI-1 were clearly evident in all thrombosed vessels examined. The signals were most prominent in endothelial and multinucleated giant cells. Some but less positivity was seen in smooth muscle cells in specific loci (Figure 2 ). Strong positive hybridization was consistently evident in the neoendothelium covering the "shoulder" of thrombi (Figure 3) , with the endothelial nature of the cell having been confirmed with antibody against thrombomodulin and against factor Vlll-related antigen. DNA synthesis was prominent at the same sites, i.e., in the endothelium covering the shoulder portions of thrombus. In contrast, results were negative in the new endothelium covering the top portion of thrombus.
Macrophages delineated with RAM-11 antibody were present surrounding the suture in its originally intraluminal and its extravascular loci as well. They exhibited strong positive hybridization signals (Figure 4) .
Endothelial cells over the thrombus exhibited higher positivity than that in cells lining adjacent undamaged arteries ( Figure 5 No hybridization was seen in contralateral noninjured carotid arteries ( Figure 6 ). Furthermore, no signals were seen when a PAI-1 sense probe was used, confirming the specificity of hybridization.
In contralateral, control, noninjured carotid arteries, no cells were positive for immunostaining with RAM-11. Medial smooth muscle cells were uniformly reactive with HHF-35, and endothelial cells were uniformly reactive with antibodies to factor Vlll-related antigen and thrombomodulin.
Staining of adjacent sections with polyclonal goat anti-human PAI-1 immunoglobulin G showed that PAI-1 antigen colocalized with PAI-1 mRNA along the luminal surface of carotid arteries, in the smooth muscle cells on the luminal side of the internal elastic lamina, and in macrophages surrounding the sutures (Figures  3-6 ). Some PAI-1 antigen was present in uninjured endothelial cells, probably reflecting constitutive secretion, but not in the regions under the internal elastic lamina. Immunohistochemical studies were always con- trolled by incubating serial sections with preimmune serum, which did not label any of the cells.
Discussion
Our results demonstrate that PAI-1 mRNA and PAI-1 protein are expressed in the walls of carotid arteries in response to thrombosis induced in the absence of a direct, gross physical insult to the arterial wall, such as electrically induced endothelial and medial injury. Suture-induced thrombosis was used as the stimulus. The changes in local expression of PAI-1 were not accompanied by persistent changes in plasma PAI-1 activity. Slight increases in plasma PAI-1 activity occurred, but only in the first week, in experimental and sham-operated animals, presumably reflecting the response to surgical intervention. Thus, the changes in vascular wall PAI-1 expression that we observed appeared to be a local consequence of the induced thrombosis.
PAI-1 protein staining and positive in situ hybridization were colocalized in the same regions of the vessel wall in serial sections. The only divergence occurred in some normal endothelial cells, which stained variably and weakly for PAI-1 immunoreactivity. In these cells, no PAI-1 mRNA was detectable. In such loci it could not be determined whether some PAI-1 protein had been secreted elsewhere, released into the circulation, and trapped in matrix in the sections we analyzed, or whether PAI-1 mRNA had been synthesized at a level below the limit of detection of the in situ hybridization procedure used. However, as judged from our results, authentic PAI-1 mRNA was present in the majority of cells in which PAI-1 protein was present.
Expression of PAI-1 mRNA was prominent in endothelial cells overlying induced thrombi, consistent with the exuberant elaboration of PAI-1 by stimulated endothelial cells in culture. 23 Of particular interest, endothelium in control vessels did not express PAI-1 mRNA that was detectable by in situ hybridization. Previous results with cells in culture suggest that endothelial cells in vitro produce a substantial quantity of PAI-1 antigen. Although they have the capacity to express PAI-1, expression may be dependent on stimuli such as those accompanying thrombosis in vivo. TGF-0 released from platelet a-granules can stimulate synthesis of PAI-1 in vitro and in vivo. Vascular injury is a consistent and unavoidable consequence of interventions, such as balloon angioplasty, that are used clinically to relieve arterial obstruction. Thrombosis often occurs in this setting as well. 25 Our results suggest that the associated neoendothelialization that was seen may potentiate thrombosis because of elaboration of PAI-1 with consequent local attenuation of fibrinolysis. The increased expression of PAI-1 in vessel walls may contribute to the evolution of restenosis as well.
Expression of PAI-1 mRNA was detected in smooth muscle cells adjacent to the internal elastic lamina underlying the thickened endothelial layer induced by thrombosis. However, it was not seen in smooth muscle cells elsewhere in the neointima. Smooth muscle cells within the media in rat carotid arteries express t-PA before they migrate into the intima. 26 Expression of PAI-1 mRNA in medial smooth muscle cells may, therefore, be a covariate associated with expression of t-PA. Expression of PAI-1 was evident in macrophages surrounding the sutures used to induce thrombosis, consistent with the observation that alveolar macrophages can express PAI-1 mRNA in response to injury. 27 Accordingly, accumulation of macrophages in arteries exposed to intraluminal foreign bodies, such as stents, may compromise the balance between thrombosis and fibrinolysis, with a consequent predisposition to thrombosis.
The possibility that localized overexpression of PAI-1 mRNA and protein contributes to recurrent thrombosis, accelerated atherogenesis, or both is being explored in ongoing studies in which antisense oligonucleotides directed against the PAI-1 gene are being used to downregulate PAI-1 expression in vivo. The present observations support the hypothesis that augmented local expression of PAI-1 in vessel walls may contribute to these phenomena and to vasculopathy under diverse pathophysiological circumstances.
